Jun Yi Pan

Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China.

Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China.

Shanghai Senyu Media Holding Co., Ltd. engages in the copyright trading and co-operating with radio and television network, media operators, and new media. The company was founded on August 5, 2010 and is headquartered in Shanghai, China.

Shenzhen Sinaean Co Tech Energy Technology Co., Ltd. operates a thermal power plant. The private company is based in Shenzhen, China.

Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.

Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.

Shanghai Vitalgen Biopharma Co., Ltd. is a company based in Shanghai, China that engages in drug research and development services. The Chinese company was founded in 2020. The CEO is Xiao Ping Zhao.